Articles

Biotech stocks with no earnings, no cash, and no path to profit will have no chance at survival. Here's three such biotech stocks to avoid. More

These three pet stocks are all worth a look, particularly by long-term investors seeking a sector with impressive growth catalysts. More

Mortgage rates are the talk of Wall Street ahead of tomorrow's Case-Shiller home price index report for February. More

With semiconductor specialist Netlist winning a patent battle against Samsung, NLST stock naturally went parabolic. More

GME stock still has short-squeeze potential. And just as importantly, GameStop is a viable business that's aiming for a full-year profit. More

AMC Entertainment is going to sell more popcorn in Walmart stores. Here's why this won't help AMC stock pull back into the green. More

Don't be enticed by Mullen Automotive's seemingly positive press release, as MULN stock is still on a short trip to a dead end. More

Subscriber Sign in